Zoledronic acid is effective in preventing and delaying skeletal events in patients with bone metastases secondary to genitourinary cancers

BJU Int. 2006 Jun;97(6):1351-2. doi: 10.1111/j.1464-410X.2006.06279_7.x.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bone Density Conservation Agents / therapeutic use*
  • Bone Neoplasms / drug therapy*
  • Bone Resorption / prevention & control*
  • Diphosphonates / therapeutic use*
  • Humans
  • Imidazoles / therapeutic use*
  • Magnesium Deficiency / chemically induced
  • Male
  • Prostatic Neoplasms / drug therapy
  • Urogenital Neoplasms*
  • Zoledronic Acid

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid